These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia. DeBaun MR J Pediatr; 2005 Oct; 147(4):560-1. PubMed ID: 16227052 [No Abstract] [Full Text] [Related]
4. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. Miller ST; Macklin EA; Pegelow CH; Kinney TR; Sleeper LA; Bello JA; DeWitt LD; Gallagher DM; Guarini L; Moser FG; Ohene-Frempong K; Sanchez N; Vichinsky EP; Wang WC; Wethers DL; Younkin DP; Zimmerman RA; DeBaun MR; J Pediatr; 2001 Sep; 139(3):385-90. PubMed ID: 11562618 [TBL] [Abstract][Full Text] [Related]
5. Sickle cell disease and stroke. Talahma M; Strbian D; Sundararajan S Stroke; 2014 Jun; 45(6):e98-100. PubMed ID: 24788968 [No Abstract] [Full Text] [Related]
6. Defining stroke risk in children with sickle cell anaemia. Hoppe C Br J Haematol; 2005 Mar; 128(6):751-66. PubMed ID: 15755278 [TBL] [Abstract][Full Text] [Related]
7. Obstacles to primary stroke prevention in children with sickle cell disease. Fullerton HJ; Gardner M; Adams RJ; Lo LC; Johnston SC Neurology; 2006 Sep; 67(6):1098-9. PubMed ID: 17000992 [No Abstract] [Full Text] [Related]
8. Prevention and management of strokes in patients with sickle cell disease. Abboud MR; Atweh GF Curr Hematol Rep; 2006 Mar; 5(1):15-22. PubMed ID: 16537042 [TBL] [Abstract][Full Text] [Related]
9. Stroke may appear to be rare in Saudi-Arabian and Nigerian children with sickle cell disease, but not in Cameroonian sickle cell patients. Njamnshi AK; Wonkam A; Djientcheu Vde P; Ongolo-Zogo P; Obama MT; Muna WF; Sztajzel R Br J Haematol; 2006 Apr; 133(2):210; author reply 211. PubMed ID: 16611314 [No Abstract] [Full Text] [Related]
10. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. Hulbert ML; Scothorn DJ; Panepinto JA; Scott JP; Buchanan GR; Sarnaik S; Fallon R; Chu JY; Wang W; Casella JF; Resar L; Berman B; Adamkiewicz T; Hsu LL; Smith-Whitley K; Mahoney D; Woods G; Watanabe M; DeBaun MR J Pediatr; 2006 Nov; 149(5):710-2. PubMed ID: 17095350 [TBL] [Abstract][Full Text] [Related]
11. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. Scothorn DJ; Price C; Schwartz D; Terrill C; Buchanan GR; Shurney W; Sarniak I; Fallon R; Chu JY; Pegelow CH; Wang W; Casella JF; Resar LS; Berman B; Adamkiewicz T; Hsu LL; Ohene-Frempong K; Smith-Whitley K; Mahoney D; Scott JP; Woods GM; Watanabe M; Debaun MR J Pediatr; 2002 Mar; 140(3):348-54. PubMed ID: 11953734 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. McCarville MB; Goodin GS; Fortner G; Li CS; Smeltzer MP; Adams R; Wang W Pediatr Blood Cancer; 2008 Apr; 50(4):818-21. PubMed ID: 18085672 [TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular accident in sickle cell disease. Alam M; Lodhi MA; Khan D J Coll Physicians Surg Pak; 2003 Jan; 13(1):55-6. PubMed ID: 12685980 [TBL] [Abstract][Full Text] [Related]
14. Thrombosis-associated gene variants in sickle cell anemia. Romana M; Muralitharan S; Ramasawmy R; Nagel RL; Krishnamoorthy R Thromb Haemost; 2002 Feb; 87(2):356-8. PubMed ID: 11858507 [No Abstract] [Full Text] [Related]
15. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Strouse JJ; Hulbert ML; DeBaun MR; Jordan LC; Casella JF Pediatrics; 2006 Nov; 118(5):1916-24. PubMed ID: 17079562 [TBL] [Abstract][Full Text] [Related]
16. Stroke in Nigerian children with sickle cell disease. Fatunde OJ; Adamson FG; Ogunseyinde O; Sodeinde O; Familusi JB Afr J Med Med Sci; 2005 Jun; 34(2):157-60. PubMed ID: 16749340 [TBL] [Abstract][Full Text] [Related]
17. Therapy insight: stroke risk and its management in patients with sickle cell disease. Kirkham FJ Nat Clin Pract Neurol; 2007 May; 3(5):264-78. PubMed ID: 17479074 [TBL] [Abstract][Full Text] [Related]
18. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Wang WC Curr Opin Hematol; 2007 May; 14(3):191-7. PubMed ID: 17414206 [TBL] [Abstract][Full Text] [Related]
19. Neurocognitive sequelae of sickle cell disease: current issues and future directions. Routhieaux J; Sarcone S; Stegenga K J Pediatr Oncol Nurs; 2005; 22(3):160-7. PubMed ID: 15855477 [TBL] [Abstract][Full Text] [Related]
20. Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Francis RB; Johnson CS Blood; 1991 Apr; 77(7):1405-14. PubMed ID: 2009364 [No Abstract] [Full Text] [Related] [Next] [New Search]